MiMedx
MDXG4.2700.95% ( +0.040 )
MiMedx (MDXG)
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues mem...
- Open
- 3.900
- High
- 4.270
- Low
- 3.760
- Prev. Close
- 4.230
- Volume
- 6.12M
- Turnover
- 24.88M
- Avg Price
- 4.067
- Bid/Ask Ratio
- --
- Amplitude
- 12.06%
- 52wk High
- 7.990
- Volume Ratio
- 5.48
- Turnover Ratio
- 5.19%
MiMedx Analyst Rating
View MoreForecast & Rating
Jul 30, 2026Price forecast
$6.6054.57%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 6 hours ago
13:16 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)
- prnewswire · 15 hours ago
03:59 ETShareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
- Market Beat · 1 day ago, 06:04 PM
MiMedx Group Q2 Earnings Call Highlights
- PUBT · 1 day ago, 03:27 PM
MiMedx Q2 FY26 net loss widens to $14.84 million; net sales drop 34.7% to $64.36 million
- Earnings Watch · 1 day ago, 03:20 PM
MiMedx | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 64.36 M
- PUBT · 1 day ago, 03:02 PM
MiMedx to buy Sanara MedTech in cash-and-stock deal valued at USD 35 a share
